Koppers Holdings Valuation

Is KOP undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of KOP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: KOP ($36.62) is trading below our estimate of fair value ($155.23)

Significantly Below Fair Value: KOP is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for KOP?

Other financial metrics that can be useful for relative valuation.

KOP key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.8x
Enterprise Value/EBITDA7.3x
PEG Ratio1.3x

Price to Earnings Ratio vs Peers

How does KOP's PE Ratio compare to its peers?

The above table shows the PE ratio for KOP vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average29.7x
OEC Orion
12.3x36.2%US$965.2m
WLKP Westlake Chemical Partners
13.8xn/aUS$784.2m
ASIX AdvanSix
85.1x117.6%US$721.0m
SIRE Sisecam Resources
7.6xn/aUS$511.9m
KOP Koppers Holdings
9.5x7.2%US$751.4m

Price-To-Earnings vs Peers: KOP is good value based on its Price-To-Earnings Ratio (9.5x) compared to the peer average (37.1x).


Price to Earnings Ratio vs Industry

How does KOP's PE Ratio compare vs other companies in the US Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a15.7%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a15.7%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: KOP is good value based on its Price-To-Earnings Ratio (9.5x) compared to the US Chemicals industry average (25.4x).


Price to Earnings Ratio vs Fair Ratio

What is KOP's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

KOP PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio9.5x
Fair PE Ratio13.8x

Price-To-Earnings vs Fair Ratio: KOP is good value based on its Price-To-Earnings Ratio (9.5x) compared to the estimated Fair Price-To-Earnings Ratio (13.8x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst KOP forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$36.62
US$64.50
+76.1%
0.8%US$65.00US$64.00n/a2
Sep ’25US$39.58
US$64.50
+63.0%
0.8%US$65.00US$64.00n/a2
Aug ’25US$38.41
US$64.50
+67.9%
0.8%US$65.00US$64.00n/a2
Jul ’25US$36.16
US$64.50
+78.4%
0.8%US$65.00US$64.00n/a2
Jun ’25US$44.33
US$64.50
+45.5%
0.8%US$65.00US$64.00n/a2
May ’25US$52.35
US$64.50
+23.2%
0.8%US$65.00US$64.00n/a2
Apr ’25US$54.79
US$64.50
+17.7%
0.8%US$65.00US$64.00n/a2
Mar ’25US$52.97
US$64.50
+21.8%
0.8%US$65.00US$64.00n/a2
Feb ’25US$52.66
US$64.50
+22.5%
0.8%US$65.00US$64.00n/a2
Jan ’25US$51.22
US$47.50
-7.3%
5.3%US$50.00US$45.00n/a2
Dec ’24US$45.14
US$47.50
+5.2%
5.3%US$50.00US$45.00n/a2
Nov ’24US$36.90
US$47.50
+28.7%
5.3%US$50.00US$45.00n/a2
Oct ’24US$39.55
US$47.50
+20.1%
5.3%US$50.00US$45.00n/a2
Sep ’24US$39.90
US$47.50
+19.0%
5.3%US$50.00US$45.00US$39.582
Aug ’24US$38.60
US$41.67
+7.9%
15.0%US$50.00US$35.00US$38.413
Jul ’24US$34.10
US$42.50
+24.6%
13.2%US$50.00US$35.00US$36.164
Jun ’24US$29.19
US$42.50
+45.6%
13.2%US$50.00US$35.00US$44.334
May ’24US$33.13
US$42.50
+28.3%
13.2%US$50.00US$35.00US$52.354
Apr ’24US$34.97
US$42.50
+21.5%
13.2%US$50.00US$35.00US$54.794
Mar ’24US$38.12
US$42.50
+11.5%
13.2%US$50.00US$35.00US$52.974
Feb ’24US$34.48
US$40.50
+17.5%
19.5%US$50.00US$29.00US$52.664
Jan ’24US$28.20
US$40.50
+43.6%
19.5%US$50.00US$29.00US$51.224
Dec ’23US$29.89
US$40.50
+35.5%
19.5%US$50.00US$29.00US$45.144
Nov ’23US$25.03
US$39.50
+57.8%
23.8%US$50.00US$25.00US$36.904
Oct ’23US$20.78
US$39.50
+90.1%
23.8%US$50.00US$25.00US$39.554
Sep ’23US$22.44
US$40.00
+78.3%
21.6%US$50.00US$27.00US$39.904

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies